Bank of America
BHVN

Bank of America’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bank of America’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-427,832
Closed -$64.7M – 8822
2022
Q3 		$64.7M Buy
427,832
+302,714
+242% +$44.9M 0.01% 1086
2022
Q2 		$18.2M Sell
125,118
-188,157
-60% -$24M ﹤0.01% 2098
2022
Q1 		$37.1M Buy
313,275
+37,914
+14% +$4.73M ﹤0.01% 1596
2021
Q4 		$37.9M Buy
275,361
+30,824
+13% +$3.92M ﹤0.01% 1627
2021
Q3 		$34M Buy
244,537
+6,159
+3% +$769K ﹤0.01% 1650
2021
Q2 		$23.1M Buy
238,378
+33,278
+16% +$2.7M ﹤0.01% 2007
2021
Q1 		$14M Buy
205,100
+60,095
+41% +$4.86M ﹤0.01% 2371
2020
Q4 		$12.4M Buy
145,005
+33,979
+31% +$2.88M ﹤0.01% 2305
2020
Q3 		$7.22M Sell
111,026
-1,159
-1% -$76K ﹤0.01% 2572
2020
Q2 		$8.2M Buy
112,185
+656
+0.6% +$34.9K ﹤0.01% 2399
2020
Q1 		$3.8M Buy
111,529
+26,394
+31% +$1.21M ﹤0.01% 2916
2019
Q4 		$4.63M Sell
85,135
-115,183
-58% -$5.7M ﹤0.01% 3308
2019
Q3 		$8.36M Sell
200,318
-114,230
-36% -$4.83M ﹤0.01% 2698
2019
Q2 		$13.8M Buy
314,548
+137,507
+78% +$7.75M ﹤0.01% 2211
2019
Q1 		$9.11M Buy
177,041
+83,724
+90% +$3.62M ﹤0.01% 2566
2018
Q4 		$3.45M Buy
93,317
+11,268
+14% +$406K ﹤0.01% 3361
2018
Q3 		$3.08M Sell
82,049
-46,318
-36% -$1.7M ﹤0.01% 3606
2018
Q2 		$5.07M Buy
128,367
+33,215
+35% +$1.05M ﹤0.01% 3142
2018
Q1 		$2.45M Buy
95,152
+17,333
+22% +$518K ﹤0.01% 3728
2017
Q4 		$2.1M Sell
77,819
-75,551
-49% -$2.08M ﹤0.01% 3900
2017
Q3 		$5.73M Buy
153,370
+55,052
+56% +$1.67M ﹤0.01% 3060
2017
Q2 		$2.46M Buy
+98,318
New +$2.26M ﹤0.01% 3696

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Bank of America's BHVN Position: Q4 2022 in Review

Bank of America sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 427,832 shares — an estimated $64.7M sold.

Bank of America first reported a position in BHVN in Q2 2017 and held it in 22 quarters. The position peaked at $64.7M in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Bank of America reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Bank of America sold 427,832 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $64.7M.
  • Bank of America first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2017 and held it in 22 quarters.
  • Bank of America's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $64.7M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Bank of America's 13F filing for Q4 2022, filed 10 Feb 2023.